Alliance Pharma’s Acquisition of LGC’s Development Solutions Business

Giulia Di Palma Europe Legal Chronicle
Tagged:

Ashurst has advised LGC on the deal.LGC sold its drug development solutions (DDS) business to Alliance Pharma, a US-based bioanalytical contract research organisation and an Ampersand…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Giulia Di Palma

Author: Giulia Di Palma

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here